Clinical Trial Update: A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1) [NA]

View source ↗

Summary

This completed clinical trial evaluated fasting and postprandial ApoB-48 levels in diabetic participants with normal to moderately high LDL-C, using the investi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• MK-0653A

Snippet

Sponsor: Organon and Co | Conditions: Dyslipidemia, Hypercholesterolemia | NA | Status: COMPLETED | Results posted: 2013-04-09